Nombre de documents | Descripteur |
| 21 | Humans |
| 17 | Indium Radioisotopes (diagnostic use) |
| 16 | Female |
| 13 | Carcinoembryonic Antigen (immunology) |
| 10 | Middle Aged |
| 9 | Male |
| 8 | Animals |
| 7 | Aged |
| 7 | Colorectal Neoplasms (radionuclide imaging) |
| 7 | Mice |
| 6 | Adenocarcinoma (radionuclide imaging) |
| 6 | Adult |
| 6 | Antibodies, Monoclonal (diagnostic use) |
| 6 | Mice, Nude |
| 5 | Neoplasm Recurrence, Local (radionuclide imaging) |
| 4 | Indium Radioisotopes (pharmacokinetics) |
| 4 | Neoplasm Transplantation |
| 4 | Radioimmunodetection (methods) |
| 4 | Sensitivity and Specificity |
| 4 | Tissue Distribution |
| 4 | Tumor Cells, Cultured |
| 3 | Aged, 80 and over |
| 3 | Antibodies, Bispecific (therapeutic use) |
| 3 | Antibodies, Monoclonal (metabolism) |
| 3 | Antigens, Tumor-Associated, Carbohydrate (immunology) |
| 3 | Edetic Acid (analogs & derivatives) |
| 3 | Immunoglobulin Fab Fragments (immunology) |
| 3 | Immunoglobulin Fragments (metabolism) |
| 3 | Radioimmunodetection |
| 3 | Radioimmunotherapy |
| 3 | Thyroid Neoplasms (radionuclide imaging) |
| 3 | Transplantation, Heterologous |
| 2 | Adenocarcinoma (metabolism) |
| 2 | Antibodies, Bispecific (diagnostic use) |
| 2 | Antibodies, Bispecific (pharmacokinetics) |
| 2 | Antibodies, Monoclonal (administration & dosage) |
| 2 | Antibodies, Monoclonal (immunology) |
| 2 | Antibody Specificity |
| 2 | Antigens, Neoplasm (immunology) |
| 2 | Carcinoembryonic Antigen (analysis) |
| 2 | Carcinoembryonic Antigen (metabolism) |
| 2 | Carcinoma (radionuclide imaging) |
| 2 | Chelating Agents |
| 2 | Chelating Agents (metabolism) |
| 2 | Colonic Neoplasms (metabolism) |
| 2 | Colonic Neoplasms (radiotherapy) |
| 2 | Colorectal Neoplasms (immunology) |
| 2 | Colorectal Neoplasms (surgery) |
| 2 | Feasibility Studies |
| 2 | Haptens (therapeutic use) |
| 2 | Immunoglobulin Fab Fragments |
| 2 | Immunoglobulin Fragments (chemistry) |
| 2 | Injections, Intraperitoneal |
| 2 | Iodine Radioisotopes (therapeutic use) |
| 2 | Models, Structural |
| 2 | Ovarian Neoplasms (metabolism) |
| 2 | Ovarian Neoplasms (radionuclide imaging) |
| 2 | Ovarian Neoplasms (surgery) |
| 2 | Pentetic Acid (diagnostic use) |
| 2 | Radioimmunotherapy (methods) |
| 2 | Reproducibility of Results |
| 2 | Thyroid Neoplasms (pathology) |
| 2 | Thyroid Neoplasms (radiotherapy) |
| 2 | Time Factors |
| 2 | Tomography, Emission-Computed |
| 2 | Tomography, X-Ray Computed |
| 1 | Adenocarcinoma (blood) |
| 1 | Adenocarcinoma (diagnosis) |
| 1 | Adenocarcinoma (epidemiology) |
| 1 | Adenocarcinoma (immunology) |
| 1 | Adenocarcinoma (secondary) |
| 1 | Adenocarcinoma (surgery) |
| 1 | Antibodies (metabolism) |
| 1 | Antibodies, Anti-Idiotypic (analysis) |
| 1 | Antibodies, Anti-Idiotypic (metabolism) |
| 1 | Antibodies, Bispecific (chemistry) |
| 1 | Antibodies, Bispecific (immunology) |
| 1 | Antibodies, Bispecific (isolation & purification) |
| 1 | Antibodies, Monoclonal |
| 1 | Antibodies, Monoclonal (chemistry) |
| 1 | Antibodies, Monoclonal (isolation & purification) |
| 1 | Antibodies, Monoclonal (pharmacokinetics) |
| 1 | Antigens, Tumor-Associated, Carbohydrate |
| 1 | Antigens, Tumor-Associated, Carbohydrate (blood) |
| 1 | Benzylamines (chemistry) |
| 1 | Binding Sites |
| 1 | Biological Transport |
| 1 | Carcinoma (metabolism) |
| 1 | Carcinoma (surgery) |
| 1 | Carcinoma (therapy) |
| 1 | Carcinoma, Medullary (pathology) |
| 1 | Carcinoma, Medullary (radionuclide imaging) |
| 1 | Carcinoma, Medullary (radiotherapy) |
| 1 | Carcinoma, Medullary (secondary) |
| 1 | Carcinoma, Medullary (surgery) |
| 1 | Chelating Agents (chemical synthesis) |
| 1 | Chelating Agents (chemistry) |
| 1 | Chelating Agents (pharmacokinetics) |
| 1 | Chemistry, Physical |
| 1 | Chromatography, High Pressure Liquid |